Use of antifungals in the treatment of vulvovaginal candidiasis: an integrative review
DOI:
https://doi.org/10.26694/reufpi.v12i1.4019Keywords:
Women, Antifungal Agents, Candidiasis, VulvovaginalAbstract
Objective: To identify scientific evidence available in the literature and analyze the action of antifungal drugs used for the treatment of vulvovaginal candidiasis. Methods: Integrative literature review conducted in the databases Medline/PubMed, Embase, Web of Science, Cochrane Library, CINAHL, SCOPUS and VHL; with the descriptors "woman", "antifungal agents"; "vulvovaginal candidiasis". Results: Ten scientific articles published between 1983 and 2020 were obtained. Of these, four were developed in Iran; followed by Mexico, England, Taiwan, Thailand, Denmark, and the United States. In terms of methodological design, most studies are clinical trials (n=8), and two are cross-sectional studies. Regarding the level of evidence, eight are level II, and only two investigations are level IV. Concerning the antifungal drugs used in the treatment, there was a predominance of clotrimazole (n=4; efficacy ranging from 42.4% to 98.3%), followed by econazole (n=2; efficacy between 39% and 89%), combined or not with another antifungal drug. Conclusion: The use of clotrimazole stands out, as it is highly effective in the treatment of vulvovaginal candidiasis. This study contributes to the advancement of knowledge and improvement of the clinical practice of nursing and other health professionals. It is expected that these results will encourage further studies and update clinical practices.
References
Leal MRD, Pavie MCNCL, Tozetto SOK, Lordelo GPVS. Tratamento da candidíase vulvovaginal e novas perspectivas terapêuticas: uma revisão narrativa. Rev Pesquisa Em Fisioterapia. [Internet]. 2016;6(4). DOI: https://doi.org/10.17267/2238-2704rpf.v6i4.1021
Cruz GS, Brito EHS de, Freitas LV, Monteiro FPM. Candidíase vulvovaginal na Atenção Primária à Saúde: diagnóstico e tratamento. Rev. Enferm. Atual In Derme. [Internet]. 2020;94(32):e-020074. DOI: https://www.revistaenfermagematual.com.br/index.php/revista/article/view/735.
Luz BN, Souza RP, Franco JVV, Cruz GUS, Fonseca JB, Santana VL. Profile of women most vulnerable to developing candidiasis and its pharmacological treatment. Res., Soc. Dev. [Internet]. 2022;11(10):e35111032477. DOI: 10.33448/rsd-v11i10.32477.
Cruz JS, Ramos LM, Filadelpho LA, Brito GC, Sousa MM, Cruz GS, Santos GBO, Marques SPC, Coelho GS, Silva EF. Candidíase vulvovaginal recorrente, atualização terapêutica fitoterápica: uma revisão de literatura. REAS. [Internet]. 2022;15(11):e11220. DOI: https://doi.org/10.25248/reas.e11220.2022
Costa EGR, Campos ACC, Souza APS. Terapias para o tratamento de candidíase vulvovaginal. RRS-Estácio Goiás. [Internet]. 2020;3(02):61-7. Available from: https://estacio.periodicoscientificos.com.br/index.php/rrsfesgo/article/view/168
Lima LS, Lacerda VAM. Os efeitos do óleo essencial de melaleuca alternifolia cheel no tratamento da candidíase vulvovaginal recorrente. Alternifolia cheel no tratamento da candidíase vulvovaginal recorrente. Rev Bras Interdiscip Saúde - ReBIS. [Internet]. 2022; 4(3):20-8. Available from: https://revistarebis.rebis.com.br/index.php/rebis/article/view/382
Santos CS, Bispo IN, Souza OA. Candidíase vulvovaginal recorrente: o papel do enfermeiro. REASE. [Internet]. 2021;7(3):470–83. DOI: https://doi.org/10.51891/rease.v7i3.791
Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. [Internet]. 2005;52(5):546-553. DOI: https://doi.org/10.1111/j.1365-2648.2005.03621.x
Lockwood C, Porrit K, Munn Z, Rittenmeyer L, Salmond S, Bjerrum M, et al. Chapter 2: Systematic reviews of qualitative evidence. In: Aromataris E, Munn Z, editors. Joanna Briggs Institute; 2017.
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Systematic Reviews. 2016;5:210. DOI: https://doi.org/10.1186/s13643-016-0384-4
Marziale MH. Instrumento para recolección de datos revisión integrativa [Internet]. 2015. [Internet]. Available from: https://gruposdepesquisa.eerp.usp.br/sites/redenso/wp-content/uploads/sites/9/2016/04/Instrumento-REDENSO-Internacional-revisao-integrativa.pdf
Melnyk BM, Fineout-Overholt H. Evidence-based practice in nursing and healthcare: a guide to best practice. Philadelphia: Lippincott Williams & Wilkins; 2005.
Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. [Internet]. 2009;6(7):e1000097. DOI: https://doi.org/10.1371/journal.pmed.1000097
Romero-Cerecero O, Islas-Garduño AL, Zamilpa A, Tortoriello J. Effectiveness of Ageratina pichinchensis Extract in Patients with Vulvovaginal Candidiasis. A Randomized, Double-Blind, and Controlled Pilot Study. Phytother. Res. [Internet]. 2017. DOI: 10.1002/ptr.5802
Sarhadinejad Z, Tajadini H, Tansaz M, Bahrampour A, Sarhadynejad Z, Ansari M, et al. Comparing the Effect of Dill Seed Vaginal Cream, with a Persian Traditional Base, and 1% Clotrimazole Vaginal Cream on Vulvovaginal Candidiasis: A Double-Blind, Randomized Clinical Trial. Iran Red Crescent Med J. [Internet] 2018; 20(10):e74211. DOI: 10.5812/ircmj.74211
Khalilzadeha S, Eftkharb T, Shirbeigia L, Tabarraia M, Toliyatc T, Fayazmanesh S, et al. Efficacy of a vaginal tablet as a Persian medicine product on vulvovaginal candidiasis: a double-blind, randomised, placebo-controlled trial. Pharmaceutical biology. [Internet]. 2020;58(1):574–80. DOI: https://doi.org/10.1080/13880209.2020.1784236
Thamkhantho M, Chayachinda C. Vaginal tablets of dequalinium chloride 10 mg versus clotrimazole 100 mg for vaginal candidiasis: a double‑blind, randomized study. Arch of Gynecology and Obstetrics. [Internet]. 2020. DOI: https://doi.org/10.1007/s00404-020-05784-z
Shiravani Z, Poordast T, Alamdarloo SM, Najib FS, Hosseinzadeh F, Shahraki HR. Chamomile Extract versus Clotrimazole Vaginal Cream in Treatment of Vulvovaginal Candidiasis: A Randomized Double-Blind Control Trial. Journ of Pharmacopuncture. [Internet]. 2021;24(4):191-5. DOI: https://doi.org/10.3831/KPI.2021.24.4.191
Wang PH, Chao HT, Chen CL, Yuan CC. Single-dose Sertaconazole Vaginal Tablet Treatment of Vulvovaginal Candidiasis. J Chin Med Assoc. [Internet]. 2006;69(6). DOI: 10.1016/S1726-4901(09)70253-9
Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis. N Engl J Med. [Internet]. 2004;351-9. DOI: 10.1056/NEJMoa033114
Sharma JB, Buckshee K, Gulati N. Oral Ketoconazole and Miconazole Vaginal Pessary Treatment for Vaginal Candidosis. NZ J Obstet Gynaecol. [Internet]. 1991;31(3):276-78. DOI: 10.1111/j.1479-828x.1991.tb02798.x.
Leegaard M. Treatment of vaginal candidosis with tioconazole 2% vaginal cream. Acta Obstet Gynecol Scand. [Internet]. 1985;64:127-9. DOI: 10.3109/00016348509154704
Gabriel G, Thin RNT. Clotrimazole and econazole in the treatment of vaginal candidosis: A single-blind comparison. Br J VenerDis. [Internet]. 1983;59:56-9. DOI: 10.1136/sti.59.1.56
Sobel JD, Akins R. Determining Susceptibility in Candida Vaginal Isolates. ASM Journals. [Internet]. 2022;66(6). DOI: https://doi.org/10.1128/aac.02366-21
Marinho CAG, Neves IF. Regulamentação do uso medicinal e científico da cannabis no Brasil. REASE. [Internet]. 2022;8(11). DOI: doi.org/10.51891/rease.v8i11.7721
Araújo RV, Soares AAB, Oliveira AKA. Fatores relacionados a candidíase vulvovaginal nas mulheres em seu ciclo vital: uma revisão integrativa. RECIMA21 -Ciências Exatas e da Terra, Sociais, da Saúde, Humanas e Engenharia/Tecnologia. [Internet]. 2022;3(10):e3102021. DOI: https://doi.org/10.47820/recima21.v3i10.2021
Marçon C, Pereira BAS, Mendes RP, Nogueira VSN. Distribuição de espécies de agentes de candidemia em hospitais da américa latina: revisão sistemática e meta-análise. Resultados preliminares. BJID. [Internet]. 2022;26(supp.02). DOI: https://doi.org/10.1016/j.bjid.2022.102610
Alves KQ, Santos ACAO, Cavalcanti DSP, Batista FL. Aspectos gerais da candidíase vulvovaginal: uma revisão de literatura. SAÚDE & CIÊNCIA EM AÇÃO. [Internet]. 2022;8(1). Available from: http://www.revistas.unifan.edu.br/index.php/RevistaICS/article/view/970
Patel AP, Patel JK. Sertaconazole In-Situ Gel for Vulvovaginal Candidiasis. The pharma review. [Internet]. 2019. Avaiable from: https://www.researchgate.net/profile/Anita-Patel/publication/341932033_Sertaconazole_insitu_gel_for_vulvovaginal_candidiasis/links/5eda1dff92851c9c5e818d97/Sertaconazole-in-situ-gel-for-vulvovaginal-candidiasis.pdf
Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis (IST). 1a ed. Brasília: Ministério da Saúde; 2022.
Rocha WRV, Nunes LE, Neves MLR, Ximenes ECPA, Albuquerque MCPA. Gênero Candida-Fatores de virulência, Epidemiologia, Candidíase e Mecanismos de resistência. Res., Soc. Dev. [Internet]. 2021;10(4): e43910414283. DOI: 10.33448/rsd-v10i4.14283.
Nicolodi MAD, Daniell G. Um panorama sobre os mecanismos de resistência da cândida albicans e o tratamento da candidíase recorrente. RECIMA21 - Ciências Exatas e da Terra, Sociais, da Saúde, Humanas e Engenharia/Tecnologia. [Internet]. 2023;4(3): e432867. DOI: https://doi.org/10.47820/recima21.v4i3.2867
Assis ARM, Santos TC, Batista CM, Guedes VR, Siqueira IB. O uso de óleos essenciais utilizado como terapia complementar no tratamento da candidíase: uma revisão da literatura. Ciências Biológicas e de Saúde Unit. [Internet]. 2023;8(1):77-89. Available from: https://periodicos.set.edu.br/cadernobiologicas/article/view/11336
Campos T, Cosentino C, Simioni PU, Ugrinovich L. Avaliação do comportamento de levedurasdo gênero Candida a fármacos antifúngicos. Rev Ciencia & Inovação. [Internet]. 2020;5(1):17-24. Available from: https://faculdadedeamericana.com.br/ojs/index.php/Ciencia_Inovacao/article/view/461
Melika LK, Shahla RM. Antifungal susceptibility pattern of Candida isolates against six antifungal drugs by microdilution method isolated from vulvovaginal candidiasis. Int. J. Med. Microbiol. [Internet]. 2022;12(1):1605-11. Avaiable from: https://ijmcm.tonekabon.iau.ir/article_691083_9686706400975f07b27a61fa67aff1bb.pdf
Santana AC, Castro AP, Paiva MC. Compostos naturais com ação inibitória contra Candida tropicalis e Candida glabrata: uma revisão. BJHP. [Internet]. 2022;4(2):21-32. DOI: 10.29327/226760.4.2-2
Santos MM, Ferreira KCB, Santos-Valle ABC, Diniz IOM, Fabri RL, Pittella F, et al. Avaliação físico-química e biológica de nanoemulsão contendo clotrimazol como alternativa terapêutica para o tratamento de candidíase vulvovaginal. Brazilian Journal of Health and Pharmacy. [Internet]. 2020;2(1),60–8. DOI: https://doi.org/10.29327/226760.2.1-6
Martiniano CS, Coêlho AA, Souza MB, Brandão ICA, Silva AKF, Uchôa SAC. Caracterização da prescrição de medicamentos por enfermeiros nos protocolos de Atenção Primária à Saúde. Rev enferm UERJ. [Internet]. 2016; 24(3):e13923. DOI: http://dx.doi.org/10.12957/reuerj.2016.13923
Cruz-Neto J, Santos PSP, Oliveira CJ, Silva KVLG, Oliveira JD, Cavalcante TF. Contributions of Advanced Practice Nursing to Primary Health Care: A Scoping Review. Aquichan. [Internet]. 2023;23(1):e2315. DOI: https://doi.org/10.5294/aqui.2023.23.1.5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Rev Enferm UFPI
This work is licensed under a Creative Commons Attribution 4.0 International License.
Autores mantém os direitos autorais e concedem à REUFPI o direito de primeira publicação, com o trabalho licenciado sob a Licença Creative Commons Attibution BY 4.0 que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
